Process design and scale-up elements for solvent mediated polymorphic controlled tecastemizole crystallization

Organic Process Research and Development

Volumn 9, Issue 6, 2005, Pages 911-922

  Saranteas, Kostas ^a   Bakale, Roger ^a   Hong, Yaping ^a,b   Luong, Hoa ^a,c   Foroughi, Reza ^a   Wald, Stephen ^a  

^a SUNOVION PHARMACEUTICALS INC   (United States)

^b VioQuest Pharmaceuticals   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28944451804     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op050101n     Document Type: Article

References (17)

1. Threlfall, T. Structural and Thermodynamic Explanations of Ostwald's Rule. Org. Process Res. Dev. 2003, 7, 1017-1027.
2. Tavare, N. S. Industrial Crystallization: Process Simulation Analysis and Design; Plenum Press: New York, 1995.
3. Beckmann, W. Seeding Strategies for the Crystallization of the Desired Polymorph. Possibilities and Limitations. 1st International Symposium on Aspects of Polymorphism and Crystallization, Hinckley, Leicestershire, U.K., 1999.
4. Cardew, P. T.; Davey R. J. The Kinetics of Solvent-mediated Phase Transformation. Proc. R. Soc. London 1985, A398, 415-428.
5. Kitamura, M. Polymorphism in the Crystallization of L-Glutamic Acid. J. Cryst. Growth 1989, 96, 541-546.
6. Brecevic, L.; Skrtic, D.; Garcide, J. Transformation of Calcium Oxalate Hydrates. J. Cryst. Growth 1989, 96, 541-546.
7. Ogino, T.; Suzuki, T.; Sawada, K. The Rate and Mechanism of Polymorphic Transformation of Calcium Carbonate in Water; J. Cryst. Growth 1990, 100, 159-167.
8. Wang, F.; Wachter, J. A.; Antosz, F. J.; Berglund K. A. An Investigation of Solvent-Mediated Polymorphic Transformation of Progesterone Using in Situ Raman Spectroscopy. Org. Process Res. Dev. 2000, 4, 391-395.
9. Chong-Hui Gu et al. Influence of Solvents on the Rate of Solvent-Mediated Polymorphic Transformation. J. Pharm. Sci. 2001, 90 (11).
10. Herbstein, F. H. Diversity Amidst Similarity: A Multidisciplinary Approach to Phase Relationships, Solvates, and Polymorphs. J. Cryst. Growth Des. 2004, 4 (6), 1419-1429.
11. Handley, D. A.; Magnetti, A.; Higgens, A. J. Therapeutic Advantages of Third-generation Antihistamines. Exp. Opin. Invest. Drugs 1998, 7, 1045-1054.
12. Janssens et al. Bicyclic Heterocyclyl Containing N-(Bicyclic Heterocyclyl)-4-Piperidinamines. U.S. Patent No. 4,695,569 issued on September 22, 1987.
13. Hong, Y.; Bakale, R.; Senanayake, C. Method for Synthesizing 2-Substituted Imidazoles. U.S. Patent No. 5,817,823 issued on October 6, 1998.
14. Maynard, G. et al. Substituted n-Methyl-n-(4-(1H-benzimidazol-2-yl-amino) -piperidin-1-yl)-2-(aryl)butyl Benzamides Useful for the Treatment of Allergic Diseases. U.S. Patent No. 5,922,737 issued on July 13, 1999.
15. Bakale, R.; Senanayake, C.; Hong, Y.; Saranteas, K.; Redmon, M.; Wald, S. U.S. Patent No. 6,627,646 issued on September 30, 2003.
16. Solid State Chemical/Pharmaceutical Information (SSCI), Inc., West Lafayette, IN, personal communications.
17. Emmett, P. H.; Brunauer, S. J. Am. Chem. Soc. 1937, 59, 1553.